Pulmonary Infectious Diseases

 

CLICK HERE TO JOIN ME


Lung and airway infections are commonly referred to as pulmonary or respiratory infections. Chronic bronchitis, COPD, influenza, tuberculosis, and pneumonia are some of the major forms of respiratory infections. 

Nasopharyngeal infections that result in nasal discharge, bronchitis that leads to cough and sputum, and pneumonia that leads to cough with sputum can also increase the respiratory rate and lead to breathing difficulties. 

There are several viruses that contribute to the increased incidence of bronchitis, while bacteria are known to contribute to pneumonia. 

These infections usually spread from infected patients to healthy people through contaminated droplets released into the air when the infected person sneezes and coughs.

These respiratory conditions are the leading causes of mortality and morbidity from infectious diseases across the world. Nearly four million people are estimated to die due to acute respiratory infection every year. About 98% of these deaths occur due to infections in the lower respiratory tract. Mortality rates are higher in children, infants, and the elderly, particularly in the middle-income and low-income countries. 

Respiratory infections are also frequent causes of consultation and admission to healthcare facilities. 

The incidence of specific respiratory infections, their distribution, and outcomes vary according to factors such as:

  • Environmental conditions air pollutants, humidity, hygiene, household crowding, temperature, and season

  • Effectiveness and availability of medical care or infection prevention and control measures to contain the spread likes vaccines and isolation capacity

  • Host factors like age, history of smoking, nutritional status, immune status, concurrent infections with other pathogens, or underlying medical conditions

  • Pathogenic characteristics like the modes of transmission, virulence factors, transmissibility, and microbial load 

Doctors and nurses should be aware of the factors that increase or decrease the risk of spread of respiratory infections. It will help them contain the spread of the infection from the patient to others and minimize the incidence of respiratory infections. 

Preventive measures for respiratory infection control can also help to reduce the rising burden on the healthcare system and reduce the mortality and morbidity associated with these conditions. 

You can learn more about pulmonary infections and how to prevent them by attending our ‘Respiratory Webinar Offering The Mandatory Three Lectures of Patient Safety, Medical Ethics, and Infection Control’ on 10th November from 4 pm to 7 pm. 

Our respiratory webinars are focused on educating healthcare professionals about the management of pulmonary infections. We will also discuss the medical ethics involved in the attitude and practices of physician-assisted suicide in the united states. You will also learn about the prevailing healthcare quality and the need to improve healthcare services to prevent medical errors and ensure optimum patient safety. 

Join this respiratory conference to keep yourself updated about the latest advancements in the medical field and learn the preventive measures for reducing the incidences of pulmonary infections. 



Popular posts from this blog

RESPIRATORY THERAPY TOPICS ON SLEEP MEDICINE WEBINAR

A & T Lectures Sleep Medicine Webinar Respiratory Conference that is considered live or traditional CEU’s. You can interact and ask questions after the presentation. Hosted by A & T Lectures Using Zoom Video Communications We will be offering 5 Live/Webinar AARC approved CEU’s October 22 @ 4:00 pm - 9:00 pm  CONFERENCE SCHEDULE AND INSTRUCTION ON ACCESSING THIS WEBINAR Register for the conference Special note: You can join the conference for free but only those that register will get the 5 CEU’s Download ZOOM to your computer or laptop/desktop (its free) Practice using ZOOM with a friend before entering the webinar as this will not be the right time to teach you how to access the conference Make sure you join the webinar by accessing this link 10 minutes before the conference. Join The Webinar
Read more

Pulmonary Fibrosis – Symptoms, Causes, Stages, and Treatment

Image
Pulmonary fibrosis is a lung disorder that occurs when the tissues in the lungs become damaged followed by scarring. Scaring results in the formation of thick and stiff tissue that makes it more difficult for the lungs to expand and relax preventing them from working properly. As pulmonary fibrosis becomes worsens, the patient becomes short of breath in a progressive manner. The scarring linked to pulmonary fibrosis is often caused due to a combination of factors. However, in most cases, it is difficult to detect the exact cause that triggered the development of this condition. When no specific cause can be found, the condition is called idiopathic pulmonary fibrosis. The damage caused due to pulmonary fibrosis cannot be reversed. However, medications and treatment may sometimes help to ease the symptoms and improve the patient's quality of life. In some patients, a lung transplant may be required. Stages of pulmonary fibrosis Stage 1: Recent diagnosis The common early
Read more

Management Of Respiratory Failure In COVID Patients

Image
Management Of Respiratory Failure In COVID Patients It’s been more than 8 months now and still, the COVID-19 pandemic shows no sign of decline in the number of cases. What makes the COVID-19 pandemic a major cause of concern is the high risk of mortality associated with it, particularly due to respiratory failure. COVID-19 has a higher tropism for the lung and is known to cause severe pneumonia and ARDS (acute respiratory distress syndrome), especially in patients with a weak immune system and existing co-morbidities. This marks the need for the physicians, nurses, and healthcare workers to stay abreast of the latest information about the risk of ARDS and the recommended protocol for the management of respiratory distress in COVID-19 patients. Clinical features of ARDS in COVID-19 patents Most patients with COVID-induced respiratory distress meet the Berlin definition of ARDS. However, some patients may exhibit a different phenotype of ARDS with lower lung weight, higher lu
Read more